Strategies against multidrug-resistant tuberculosis

Kekkaku

Volumn 79, Issue 11, 2004, Pages 669-687

  Takashima, Tetsuya ^a,c   Kawabe, Yoshiko ^b  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b TOKYO NATIONAL HOSPITAL   (Japan)

^c Respiratory and Allergic Diseases   (Japan)

Author keywords

Case management; Chemoprophylaxis; MDR TB; Treatment

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOSALICYLIC ACID; CYCLOSERINE; ENVIOMYCIN; ETHAMBUTOL; ETHIONAMIDE; GAMMA INTERFERON; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

BACTERIAL TRANSMISSION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CLONAL ANERGY; CONFERENCE PAPER; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; IMMUNOTHERAPY; JAPAN; LUNG SURGERY; LUNG TUBERCULOSIS; MEDICAL SOCIETY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; QUESTIONNAIRE; SIDE EFFECT; SKIN TOXICITY; SPUTUM SMEAR; T LYMPHOCYTE; THORAX RADIOGRAPHY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; TUBERCULIN TEST; TUBERCULOSIS CONTROL;

EID: 13544268718     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)